View of Effect of SGLT-2 inhibitors on hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus and MASLD

Return to Issue Details Effect of SGLT-2 inhibitors on hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus and MASLD Download Download PDF